Micro-Nano Technology for Genomics and Proteomics BioMEMs - Ozkan
.pdf243
Technology Reference
SPOT [203]
SPOT [262]
SPOT [318]
SPOT [344]
DIPP [380]
SPOT [427]
SPOT [459]
SPOT [506]
SPOT [568]
SPOT [611]
SPOT [196]
DIPP [395]
SPOT [477]
(cont.)
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
GST fusions of GRB-SH2, |
complete L-amino acid substitutional |
|
|
SHP2-CSH2, GRB7-SH2, GRB |
analysis of AXXXX[pYT]XXXXA |
|
|
10-SH2 |
|
|
|
protein kinase A (PKA), Cdc 15 |
complete L-amino acid substitutional |
|
|
|
analysis of |
|
|
|
AX1X1X1X1[S/T]X1X1X1X1A X = |
|
|
|
L-amino acids exept for Cys, X1 = |
|
|
|
L-amino Acids exept for Cys, Ser, Thr |
|
|
Antibody Epitope Mapping: Discontinuous Epitopes |
|
|
|
anti-β-factor XIIa mab 201/9 |
combinatorial starting library |
SPOT |
[169] |
|
XOXOXXXX and positional |
|
|
|
scanning deconvolution libraries |
|
|
3 anti-β-factor XIIa mabs |
peptide scan of β-factor XIIa, alanine |
SPOT |
[170] |
|
walks and truncation analyses of |
|
|
|
selected peptides |
|
|
anti-IL-10 mab; anti-TNFα mabs; |
peptide scans of IL-10; TNFα; 55-kDa |
SPOT |
[444] |
TNFα |
TNFα receptor |
|
|
anti-prion protein (PrP) mabs 15B3 |
peptide scans of bovine PrP |
SPOT |
[267] |
and 6H4 |
|
|
|
anti-complement receptor 2 (CR2) |
peptide scan of the short consensus |
SPOT |
[429] |
mab FE8 |
repeats 1 and 2 (SCR-1, SCR-2) of |
|
|
|
the complement receptor 2 (CR2) |
|
|
anti-interleukin-10 (IL-10) mab |
peptide scan and hybritope scan of IL-10 |
SPOT |
[445] |
CB/RS/5 |
|
|
|
interleukin 10 (IL-10); interleukin 10 |
peptide scans of IL-10 and IL-10Rα |
SPOT |
[446] |
receptor a (IL-10Rα); 3 anti-IL-10 |
|
|
|
mabs; 1 anti-IL-10Rα mab |
|
|
|
anti-actin mab 2G2 |
partial peptide scan of actin |
SPOT |
[180] |
anti-interleukin 10 (IL-10) mab |
peptide scan of IL-10; substitutional |
SPOT |
[448] |
CB/RS/1 |
analyses; cyclization scan |
|
|
2 anti-interleukin 10 (IL-10) mabs |
peptide scans of IL-10 and substitutional |
SPOT |
[449] |
|
analyses of selected peptides |
|
|
2 anti-huIgG hinge region scFv |
substitutional analyses of dimeric |
SPOT |
[588] |
|
peptides derived from the hinge |
|
|
|
regions of IgG1, IgG2, and IgG4 |
|
|
3 anti-thyroid peroxidase scFv |
peptide scans of thyroid peroxidase (no |
SPOT |
[76] |
|
binding observed indicating a |
|
|
|
discontinuous epitope) |
|
|
anti-interleukin 10 (IL-10) mab |
peptide scan of IL-10; substitutional |
SPOT |
[451] |
CB/RS/1 |
analyses; cyclization scan |
|
|
anti-hen-eg white lysozyme (HEL) |
duotope scan of hen-eg white lysozyme |
|
|
mab D1.3 |
(HEL) |
|
|
anti-interleukin 10 (IL-10) mab |
peptide scan of IL-10; substitutional |
SPOT |
[452] |
CB/RS/1 |
analyses; cyclization scan |
|
|
4 mabs against Grapevine virus A |
peptide scans of the capsid protein of |
SPOT |
[109] |
|
Grapevine virus A |
|
|
5 murine mabs against glycoprotein |
peptide scans of gG-2 of HSV-2 |
SPOT |
[322] |
G-2 (gG-2) of herpes simplex virus |
|
|
|
type 2 (HSV-2) |
|
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
245 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
anti-FVIII mab ESH8 |
ESH8 binding peptides identified by |
SPOT |
[567] |
|
phage display; peptide scan of the |
|
|
|
C2 domain of blood coagulation |
|
|
|
factor VIII |
|
|
anti-CD30 mabs Ber-H2, Ki-2, Ki-4, |
peptide scans of the extracellular |
SPOT |
[114] |
R4-4 |
domain of CD30 and substitutional |
|
|
|
analyses of selected antibody |
|
|
|
binding peptides |
|
|
|
|
|
|
Antibody Paratope Mapping |
|
|
|
thyroglobulin; lysozyme; angiotensin |
peptide scans of the variable regions of |
SPOT |
[290] |
II |
the anti-thyroglobulin mab Tg10, |
|
|
|
anti-lysozyme antibody HyHEL-5, |
|
|
|
and anti-angiotensin II mab 4D8 |
|
|
hen egg-white lysozyme; anti-idiotypic |
peptide scan of the variable regions of |
SPOT |
[291] |
mab AI-10 (anti-thyroglobulin mab |
anti-lysozyme antibody HyHEL-5 |
|
|
Tg10) |
and anti-thyroglobulin mab Tg10 |
|
|
CD4 |
peptide scan of the variable regions of |
SPOT |
[374] |
|
anti-CD4 mab ST40 |
|
|
anti-idiotypic mab AI-10 |
peptide scan of the variable regions of |
SPOT |
[292] |
(anti-thyroglobulin mab Tg10) |
anti-thyroglobulin mab Tg10 |
|
|
CD4 |
alanine scans of 3 peptides derived |
SPOT |
[432] |
|
from the CDRs of anti-CD4 mab |
|
|
|
ST40 |
|
|
angiotensin II |
peptide scan of the variable domain of |
SPOT |
[90] |
|
anti-angiotensin II mab 4D8 |
|
|
Review article describing the application of peptide arrays to identify critical |
SPOT |
[293] |
|
paratope residues for antigen binding and the identification of antigen binding |
|
|
|
peptides thereof |
|
|
|
CD4 |
alanine substitution scan of peptides |
SPOT |
[38] |
|
from the anti-CD4 Fab 13B8.2 |
|
|
|
paratope |
|
|
|
|
|
|
Protein-Protein Interactions |
|
|
|
Protein-Protein Interactions in General |
|
|
|
procine transferrin (3 different |
peptide scan of TfbA of Actinobacillus |
SPOT |
[531] |
detection methods: (i) |
pleuropneumoniae |
|
|
immunologically, (ii) 59Fe-loaded |
|
|
|
transferring, (iii) biotinylated |
|
|
|
transferrin and streptavidin-alkaline |
|
|
|
phosphatase) |
|
|
|
35S-Met-labeled protein extract from |
peptide scans of the TNFR-R55 |
SPOT |
[2] |
Jurkat cells containing the novel |
cytoplasmic domain |
|
|
WD-repeat protein FAN |
|
|
|
calmodulin |
peptide scans of the cytoplasmic |
SPOT |
[125] |
|
domains of C-CAM1 and C-CAM2 |
|
|
|
(rat) and BGP (mouse) and Bgp |
|
|
|
(man) |
|
|
anti-IL-10 mab; anti-TNFα mabs; |
peptide scans of IL-10, TNFα, 55-kDa |
SPOT |
[444] |
TNFα |
TNFα receptor |
|
|
S100C (EF-hand-type Ca2+ binding |
peptide scan of the N-terminal region |
SPOT |
[505] |
protein) |
of annexin I |
|
|
(cont.)
246 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
soluble interleukin 6 receptor |
peptide scans of IL-6 and IL-6R; |
SPOT |
[582] |
(sIL-6R); interleukin 6 (IL-6) |
substitutional analyses of IL-6 |
|
|
|
derived peptides |
|
|
human transferrin (huTf) |
peptide scan of the |
SPOT |
[461] |
|
transferrin-binding protein B |
|
|
|
(TbpB) from Neisseria |
|
|
|
meningitidis (strain M982) |
|
|
125I-calmodulin |
phosphorylated and |
SPOT |
[126] |
|
unphosphorylated peptides derived |
|
|
|
from cell-cell adhesion molecule |
|
|
|
(C-CAM) isoforms S and L and |
|
|
|
single site substitution analogs |
|
|
porcine protein kinase C β and |
partial peptide scans of the C-CAM |
|
|
γ 32P-ATP |
isoforms S and L |
|
|
32P-labeled CaBP1 and CaBP2; |
peptide scan of the erd2 receptor |
SPOT |
[234] |
peptides LEKDEL and |
|
|
|
CYDDQKAVKDEL as |
|
|
|
competitors |
|
|
|
dimeric hepatitis B virus (HBV) core |
partial peptide scan of the HBV core |
SPOT |
[266] |
protein variants c1-149 and c1-124 |
protein 1–161 |
|
|
plasma-derived factor VIII (FVIII) |
partial peptide scan of von |
SPOT |
[379] |
and recombinant FVIII |
Willebrand factor (vWF) |
|
|
interleukin 10 (IL-10); interleukin 10 |
peptide scans of IL-10 and IL-10Rα |
SPOT |
[446] |
receptor a (IL-10Rα); 3 anti-IL-10 |
|
|
|
mabs; 1 anti-IL-10Rα mab |
|
|
|
cytosolic domains of the translocase |
peptide scans of the cytochrome c |
SPOT |
[62] |
of the outer mitochondrial |
oxidase subunit IV (CoxIV) and |
|
|
membrane (Tom) 20, 22, and 70 (S. |
phosphate carrier (Pi C) preproteins |
|
|
cerevisiae) |
(S. cerevisiae) |
|
|
α−actinin |
peptide scan of zyxin |
SPOT |
[120] |
p24 (HIV-1) |
peptide scan of p24 (HIV-1) |
SPOT |
[205] |
tubulin; γ -tubulin |
peptide scans of α-, β-, and γ -tubulin |
SPOT |
[331] |
125I vascular endothelial growth |
peptide scans of VEGF receptor II; |
SPOT |
[417] |
factor (VEGF) |
substitutional analysis of a selected |
|
|
α−actinin |
peptide |
|
|
peptide scan of zyxin |
SPOT |
[460] |
|
N-lobe, C-lobe, and complete |
peptide scans of human transferrin |
SPOT |
[463] |
transferrin binding protein B |
(hTf) |
|
|
(TbpB) from Neisseria |
|
|
|
meningitidis; TbpB from |
|
|
|
Moraxella catarrhalis |
|
|
|
CD4; anti-gp17 polyclonal antibody |
peptide scan of gp17; alanine walks |
SPOT |
[28] |
|
of selected peptides |
|
|
cytoplasmic and core domain of |
peptide scan of the phosphate carrier |
SPOT |
[63] |
mitochondrial import receptor |
protein |
|
|
Tom70 from Saccaromyces |
|
|
|
cerevisiae |
|
|
|
cardiac troponin C |
scans of cardiac troponin I |
SPOT |
[146] |
α2−macroglobulin |
peptide scan of β2-microglobulin |
SPOT |
[181] |
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
247 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
secretory immunogobulin A (SIgA) |
peptide scans of the SIgA and SC |
SPOT |
[194] |
and scretory component (SC) |
binding domain of Streptococcus |
|
|
|
pneumoniae surface protein SpsA; |
|
|
|
truncation analyses of selected |
|
|
|
peptides |
|
|
ActA (L. monocytogenes) and |
peptide scans of p21-Arc and ActA |
SPOT |
[423] |
p21-Arc |
|
|
|
125I-PHF43 fragment of τ protein |
partial peptide scan of τ protein |
SPOT |
[574] |
calmodulin |
partial peptide scan of human |
SPOT |
[55] |
|
Ca2+ -calmodulin-dependent |
|
|
|
protein kinase II β chain (CaM |
|
|
|
kinase II); peptide scan of the rat |
|
|
|
N-STOP protein |
|
|
anti-α-bungarotoxin scFv C12; |
peptide scan of α-bungarotoxin |
SPOT |
[58] |
nicotinic acetylcholine receptor |
|
|
|
nAchR |
|
|
|
cpSRP, cpSRP54 and cpSRP43 from |
peptide scans of cpSRP54 and |
SPOT |
[185] |
Arabidopsis thaliana (cpSRP = |
preLhcb1 from pea |
|
|
chloroplast signal recognition |
|
|
|
particle) |
|
|
|
8 kDa dynein light chain (LC8) |
(partial) peptide scans of cellular |
SPOT |
[478] |
|
(nNOS, Kid-1 renal transcription |
|
|
|
factor, Bim, DNA cytosine methyl |
|
|
|
transferase, |
|
|
|
microtubule-associated protein, |
|
|
|
dynein heavy chain, Drosophila |
|
|
|
swallow, GKAP) and viral target |
|
|
|
proteins from Mokola virus, |
|
|
|
rabies virus and ASF virus; N- |
|
|
|
and C-terminal extensions of the |
|
|
|
consensus binding motif KSTQT |
|
|
Lyn |
partial peptide scan of the |
SPOT |
[543] |
|
erythropoietin receptor (EPOR) |
|
|
Practical protocols for the mapping of protein-protein interactions using |
SPOT |
[184] |
|
peptide arrays prepared by SPOT synthesis |
|
|
|
Puumala virus nucleocapsid protein |
partial peptide scan of the |
SPOT |
[315] |
(PUUV-N) |
C-terminal 243 amino acids of the |
|
|
|
human apoptosis enhancer Daxx |
|
|
human islet amyloid polypeptide |
peptide scan of hIAPP |
SPOT |
[358] |
(hIAPP) fused with maltose |
|
|
|
binding protein (MBP) |
|
|
|
human fibrinogen |
alanine substitution scan and |
SPOT |
[499] |
|
complete L-amino acid |
|
|
substitutional analysis of a selected peptide from FbsA (fibrinogen receptor from group B Streptococcus); control peptides
(cont.)
248 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
regulatory subunit RII from protein |
partial peptide scans of 10 different A |
SPOT |
[10] |
kinase A |
kinase anchoring proteins (AKAPs); |
|
|
|
complete L-amino acid |
|
|
|
substitutional analysis of an |
|
|
|
AKAP-specific “position-dependent |
|
|
|
scoring matrix” (PDSM) consensus |
|
|
|
sequence derived from the AKAP |
|
|
|
peptide scans |
|
|
human plasminogen |
peptide scan of pneumococcal |
SPOT |
[35] |
|
α-enolase (Eno) and length analysis |
|
|
|
of the human plasminogen biding |
|
|
|
sequence |
|
|
regulatory subunits RIα and RIIα of |
L-substitutional analysis of a 27-mer |
SPOT |
[68] |
protein kinase A |
peptide derived from the dual |
|
|
|
specific A kinase anchoring protein |
|
|
|
2 (D-AKAP2) |
|
|
E. coli YoeB-GST fusion protein |
peptide scans of E. coli YefM and |
SPOT |
[81] |
|
single site substitution analogs of a |
|
|
|
selected peptide |
|
|
PSK (a protein-bound polysaccharide |
peptide scan of chicken gizzard |
SPOT |
[165] |
from Basidiomycetes) |
regulatory light chain (RLC) of |
|
|
|
smooth muscle myosin |
|
|
125I-human soluble urokinase-type |
peptide scan of uPAR |
SPOT |
[317] |
plasminogen activator receptor |
|
|
|
suPAR |
|
|
|
Cdc42-maltose binding protein (MBP) |
peptide scan of the C-terminal half of |
SPOT |
[353] |
fusion protein in the presence of a |
IQGAP1 |
|
|
non-hydrlyzable GTP analog |
|
|
|
(GMPPMP) |
|
|
|
125I vascular endothelial growth factor |
complete D-amino acid substitutional |
SPOT |
[418] |
(VEGF) |
analyses of VEGF receptor |
|
|
|
II-derived peptides |
|
|
N-terminal clathrin domain |
partial peptide scans of auxilin |
SPOT |
[491] |
(clathrin-TD); α-ear domain of |
|
|
|
AP-2 |
|
|
|
soluble cytosolic domains of Tom20, |
peptide scan of the inner membrane |
SPOT |
[524] |
Tom22, Tom70 |
mitochondrial protein BCS1 |
|
|
αMI-domain of integrin αMβ2 |
partial peptide scans of the P2 peptide |
SPOT |
[556] |
|
of the γC domain of fibrinogen |
|
|
Tim9/Tim10 comlex |
peptide scans of Tim17, Tim22, |
SPOT |
[564] |
|
Tim23, Sc AAC2, FLX1, Hs UCP1, |
|
|
|
and 11 control peptides |
|
|
|
|
|
|
Protein Domain—Ligand Interactions |
|
|
|
γ 32P-labeled GST-WW-domain of |
substitutional analysis (including |
SPOT |
[79] |
human YAP |
phospho amino acids) of WBP-1 |
|
|
|
derived peptide GTPPPPYTVG |
|
|
WW domain of human Yes-Associated |
substitutional analysis of a peptide |
SPOT |
[323] |
Protein (hYAP) |
derived from the WW binding |
|
|
|
protein WBP |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
249 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
|
|
vasodilator-stimulated phosphoprotein |
peptide scans of ActA (Listeria |
SPOT |
[382] |
|
(VASP) and Mena (mammalian |
monocytogenes) and truncation and |
|
|
|
homolog of Drosophila Ena) both |
substitutional analyses of selected |
|
|
|
containing EVH1 domains |
peptides; a library of proline-rich |
|
|
|
(Ena-VASP homology domain 1) |
sequences from cytoskeletal |
|
|
|
|
proteins; a library of SH3 and |
|
|
|
|
WW/WWP ligands |
|
|
|
syntrophin PDZ domain |
combinatorial library of the type |
SPOT |
[501] |
|
|
XXB1B2SXV; substitutional |
|
|
|
|
analysis of a peptide ligand for the |
|
|
|
|
syntrophin PDZ domain |
|
|
|
SH3 domains of amphiphysin 1 and |
peptide scan of synaptojanin and |
SPOT |
[73] |
|
endophilin 2 |
substitutional analyses of selected |
|
|
|
|
peptides; peptides derived from |
|
|
|
|
dynamins from Drosophila, rat, |
|
|
|
32− |
humans |
|
|
|
peptide scan of zyxin |
SPOT |
[120] |
||
α actinin |
||||
P-labeled GST-hYAP WW1 and |
PPPPXPAAAA and 19 L-amino acid |
SPOT |
[138] |
|
FE65 WW domain; several mutated |
substitutions at position X |
|
|
|
WW domains to switch the |
|
|
|
|
specificity between hYAPWW1 and |
|
|
|
|
FE65 |
|
|
|
|
syntrophin PDZ domain |
library of C-terminal peptides from all |
SPOT |
[211] |
|
|
known human proteins (3514 spots); |
|
|
|
|
substitutional analysis of a selected |
|
|
|
|
peptide |
|
|
|
phospho-tyrosine –binding domain |
amyloid precursor protein (APP) |
SPOT |
[220] |
|
(PTB) of Dab1 |
derived peptides and known ligands |
|
|
|
|
of PTB domains; substitutional |
|
|
|
|
analyses of selected peptides |
|
|
|
tumor necrois factor receptor |
L- and D-amino acid substitutional |
SPOT |
[434] |
|
associated factors (TRAFs) 1, 2, 3, |
analyses of peptides derived from |
|
|
|
and 6 |
the cytoplasmatic portion of CD40 |
|
|
|
vasodilator-stimulated phosphoprotein |
substitutional analysis of an ActA |
SPOT |
[19] |
|
(VASP) EVH1 domain |
(Listeria monocytogenes) derived |
|
|
|
|
peptide |
|
|
|
STAT5a and a mutant STAT5a (STAT: |
peptide scan of the intracellular |
SPOT |
[44] |
|
signal transducer and activator of |
domain of erythropoietin receptor |
|
|
|
transcription) |
(EPOR) |
|
|
|
32P-labeled GST, GST- RSP5-WW1, |
truncation analyses, alanine |
SPOT |
[75] |
|
GST- RSP5-WW2, GST- |
substitution scans, and phospho |
|
|
|
RSP5-WW3; (RSP = reversion pf |
amino acid analogs of |
|
|
|
Spt phenotype, Saccharomyces |
carboxy-terminal domain (CTD) |
|
|
|
cerevisiae) |
derived peptides of the RNA |
|
|
|
|
polymerase II large subunit |
|
|
|
Mena (mammalian homolog of |
peptide scan of zyxin and Phe-Ala |
SPOT |
[121] |
|
Drosophila Enabled (Ena) protein) |
substitution analogs of selected |
|
|
|
|
peptides |
|
|
|
vasodilator-stimulated phosphoprotein |
peptide scans of Fyb/SLAP1 and 2 |
SPOT |
[277] |
|
(VASP) |
(Fynand SLP-76-associated |
|
|
|
|
protein |
|
|
(cont.)
250 ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI
TABLE 7.4. Continued
Screening Molecule Library Technology Reference
murine EVH1 domain of Vesl 2
C-terminal part of p53-binding protein-2 GST fusion protein
(including SH3 domain) labeled with 32P
several mutated GST-Cterm. Variants
32P-labeled GST-hYAP WW1 domain
cell lysates from erythropoietin stimulated and unstimulated cells; JAK2, SHP1, PLCγ
WW domain of human Yes-Associated Protein (hYAP)
peptide ligand of the human Yes-Associated Protein (hYAP) WW domain
Gads C-SH3-GST fusion protein; Grb2 C-SH3-GST fusion protein
human Yes-associated protein (hYAP) WW domain, rFE65 WW domain, and mMena EVH1 domain displayed on phage
2 POD-labeled peptide ligands of WW domains
6 POD labeled WW domains
5 POD labeled WW domains
SH3 domain of ScPex13p GST fusion protein (peroxisomal protein import machinery)
partial peptide scan of mGluR5 |
SPOT |
[27] |
(metabotropic glutamate receptor |
|
|
5); length analysis and X-scan of a |
|
|
selected peptide (X = degenerate |
|
|
position) |
|
|
peptide scan of hYAP (Yes-associated |
SPOT |
[139] |
protein); alanine scan and |
|
|
progressive alanine substitutions of |
|
|
a selected peptide |
|
|
peptide derived from the hYAP binding |
|
|
site and 2 substitution analogs |
|
|
partial peptide scan of p53-BP-2; |
|
|
alanine scan, progressive alanine |
|
|
substituions, and phospho amino |
|
|
acid and Glu and Asn substitution |
|
|
analogs of a selected peptide |
|
|
peptide scan of the intracellular |
SPOT |
[278] |
domain of the EPO receptor |
|
|
substitutional analyis and truncation |
SPOT |
[419] |
analysis of the peptide |
|
|
GTPPPPYTVG |
|
|
substitutional analysis human |
SPOT |
[546, 547] |
Yes-Associated Protein (hYAP) |
|
|
WW domain (44-mers) |
|
|
partial peptide scan of SLP-76; alanine |
SPOT |
[37] |
substitution scan and complete |
|
|
L-amino acid substitutional analysis |
|
|
of a selected SLP-76-derived |
|
|
peptide; peptides derived from the |
|
|
Gads binding partners UBPY, |
|
|
AMSH, BLNK; |
|
|
peptide ligands for hYAP WW |
SPOT |
[42] |
(GTPPPPYTVG), rFE65 WW |
|
|
(PPPPPPPLPAPPPQP), and mMena |
|
|
EVH1 (SFEFPPPPTDEELRL) |
|
|
domains; negative control peptide |
|
|
arrays with 42 WW domains |
DIPP |
[393] |
6 substitutional analyses of peptide |
SPOT |
|
ligands |
|
|
phospho-peptide analogs of the WW |
SPOT |
|
ligand GPPPP-pAA-P |
|
|
peptide scans of ScPex5p and |
SPOT |
[420] |
ScPex14p; L-amino acid |
|
|
substitutional analysis and |
|
|
truncation analysis of a selected |
|
|
ScPex5P peptide |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
251 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
22 different dye-labeled peptide |
11859 variants with combinatorially |
SPOT |
[548] |
ligands (e.g., dye-GTPPPPYTVG) |
designed substitutions by |
Ch. Lig. |
|
|
proteinogenic and unnatural amino |
|
|
|
acids at three positions of the hYAP |
|
|
|
WW domain |
|
|
VASP-EVH1 domain GST fusion |
peptoid building block substitutional |
SPOT |
[617] |
protein |
analysis of a VASP-EVH1 peptide |
|
|
|
ligand; combinatorial peptoid |
|
|
|
building block library of two |
|
|
|
positions within a VASP-EVH1 |
|
|
|
peptide ligand |
|
|
phospho-specific antibodies MPM2, |
complete L-amino acid substitutional |
SPOT |
[477] |
3F3/2 and PY20 |
analysis of |
|
|
|
AXXXX[pS/pT]XXXXA and |
|
|
|
AXXXX[pYT]XXXXA |
|
|
GST fusions of GRB-SH2, |
complete L-amino acid substitutional |
|
|
SHP2-CSH2, GRB7-SH2 and GRB |
analysis of AXXXX[pYT]XXXXA |
|
|
10-SH2 |
|
|
|
protein kinase A (PKA), Cdc 15 |
complete L-amino acid substitutional |
|
|
|
analysis of |
|
|
|
AX1X1X1X1[S/T]X1X1X1X1A |
|
|
|
X = L-amino acids exept for Cys, |
|
|
|
X1 = L-amino acids exept for Cys, |
|
|
|
Ser, Thr |
|
|
Protein Domain Arrays |
|
|
|
peptide ligand of the human |
substitutional analysis human |
SPOT |
[546, 547] |
Yes-Associated Protein (hYAP) |
Yes-Associated Protein (hYAP) |
|
|
WW domain |
WW domain (44-mers) |
|
|
2 POD-labeled peptide ligands of WW |
arrays with 42 WW domains |
DIPP |
[393] |
domains |
|
|
|
6 POD labeled WW domains |
6 substitutional analyses of peptide |
SPOT |
|
|
ligands |
|
|
5 POD labeled WW domains |
phospho-peptide analogs of the WW |
SPOT |
|
|
ligand GPPPP-pAA-P |
|
|
22 different dye-labeled peptide |
11859 variants with combinatorially |
SPOT |
[548] |
ligands (e.g., dye-GTPPPPYTVG) |
designed substitutions by |
Ch. Lig. |
|
|
proteinogenic and unnatural amino |
|
|
|
acids at three positions of the hYAP |
|
|
|
WW domain |
|
|
|
|
|
|
Chaperones |
|
|
|
DnaK (Escherichia coli) |
peptide scan of the heat shock |
SPOT |
[359] |
|
transcription factor σ 32 (E. coli) |
|
|
DnaK (Escherichia coli) |
peptide scans of 37 substrate proteins; |
SPOT |
[481] |
|
combinatorial peptide libraries with |
|
|
|
two defined positions |
|
|
|
(XXXXXBXBXXXXX, |
|
|
|
XXXXXBXXBXXXX) |
|
|
GroEL (Escherichia coli) |
peptide scan of Raf-1 protein kinase |
SPOT |
[209] |
SecB (Escherichia coli) |
peptide scans of 23 substrate proteine |
SPOT |
[260] |
(cont.)
252 ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
DnaK (Escherichia coli), 4 mutant |
peptide scans of the λ CI protein |
SPOT |
[482] |
analogs and 1 truncation analog |
|
|
|
Triggerfactor (TF) (Escherichia coli) |
peptide scans of E. coli proteins: |
SPOT |
[399] |
and TF-fragments |
EF-Tu (elongation factor Tu), MetE |
|
|
|
(methionine biosynthesis enzyme), |
|
|
|
ICDH (isocitrate dehydrogenase) |
|
|
|
GlnRS (glutamine-tRNA- |
|
|
|
synthetase), alkaline phosphatase, |
|
|
|
β-galactosidase, FtsZ (involved in |
|
|
|
cell division), GBP (galactose |
|
|
|
binding protein), L2 (a ribosomal |
|
|
|
protein), lambda cI, pro OmpA |
|
|
|
(pro-outer membrane protein A), |
|
|
|
sigma 32, SecA (involved in |
|
|
|
secretion and murine DHFR |
|
|
|
(dehydrofolate reductase); yeast |
|
|
|
cytochrome B2, F1βand |
|
|
|
Su9-ATPase subunits; Photinus |
|
|
|
pyralis luciferase, RNaseT1 from |
|
|
|
Aspergillus oryzae; human PrP |
|
|
|
(prion protein) |
|
|
DnaJ and DnaK (Escherichia coli) |
peptide scans of 14 substrate proteins |
SPOT |
[483] |
Tim9p-Tim10p complex of the |
peptide scan of the ADP/ATP carrier |
SPOT |
[96] |
mitochondrial intermembrane space |
(AAC) and Tim 23p |
|
|
(Tim = translocase of inner |
|
|
|
membrane) |
|
|
|
Hsc66 (E. coli); DnaK (E. coli); Hsc20 |
peptide scans of the Fe/S protein |
SPOT |
[210] |
(E. coli) as competitor in the |
E. coli IscU |
|
|
presence of ADP |
|
|
|
Dnak (E. coli) |
peptide scans of human and mouse |
SPOT |
[563] |
|
interferon-γ |
|
|
Trigger Factor and DnaK from E. coli |
peptides derived from Trigger Factor |
SPOT |
[112] |
|
and DnaK substrate proteins |
|
|
|
|
|
|
Enzyme-Substrate and Enzyme-Inhibitor Interactions |
|
|
|
Kinases and Phosphatases |
|
|
|
protein kinase A (PKA); cytoplasmic |
several combinatorial libraries with |
SODA |
[337] |
(kinase) domains of transforming |
fixed amino acids and randomized |
|
|
growth factor ß (TGFß) type I and II |
positions (17 amino acids excludinf |
|
|
receptors; γ32P-ATP |
Cys, Ser, Thr) at different positions |
|
|
protein tyrosine kinase Lyn; |
panel of 23 PKCδ-derived 15-mer |
SPOT |
[534] |
anti-phoshpo-tyrosine antibody and |
peptides |
|
|
POD-labeled second antibody for |
|
|
|
detection |
|
|
|
catalytic subunit of protein kinase A or |
combinatorial library of the type |
SPOT |
[539] |
cGMP activated protein kinase G |
XXXO1O2XXX and iterative |
|
|
and γ32P-ATP |
deconvolution libraries |
|
|
anti-porcine tubulin-tyrosine ligase |
substitutional and truncation analysis |
SPOT |
[159] |
(TTL) mab 1D3 |
of a TTL-derived peptide; |
|
|
|
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|